MCID: URT018
MIFTS: 13

Urethra Transitional Cell Carcinoma

Categories: Cancer diseases

Aliases & Classifications for Urethra Transitional Cell Carcinoma

MalaCards integrated aliases for Urethra Transitional Cell Carcinoma:

Name: Urethra Transitional Cell Carcinoma 12
Urethral Transitional Cell Carcinoma 12
Urethral Urothelial Carcinoma 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4013
NCIt 46 C6166
UMLS 69 C0863015

Summaries for Urethra Transitional Cell Carcinoma

Disease Ontology : 12 An urethra cancer that is characterized by cancer cells forming in the renal pelvis and ureter.

MalaCards based summary : Urethra Transitional Cell Carcinoma, also known as urethral transitional cell carcinoma, is related to urethritis. The drugs Gemcitabine and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Urethra Transitional Cell Carcinoma

Diseases related to Urethra Transitional Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 urethritis 9.8

Symptoms & Phenotypes for Urethra Transitional Cell Carcinoma

Drugs & Therapeutics for Urethra Transitional Cell Carcinoma

Drugs for Urethra Transitional Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Gemcitabine Approved Phase 2,Phase 1 95058-81-4 60750
2
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
3 Antibodies Phase 2,Phase 1
4 Antibodies, Monoclonal Phase 2,Phase 1
5 Immunoglobulins Phase 2,Phase 1
6 Anti-Infective Agents Phase 2,Phase 1
7 Antimetabolites Phase 2,Phase 1
8 Antimetabolites, Antineoplastic Phase 2,Phase 1
9 Antiviral Agents Phase 2,Phase 1
10 Immunosuppressive Agents Phase 2,Phase 1
11
nivolumab Approved Phase 1 946414-94-4
12
Pembrolizumab Approved Phase 1 1374853-91-4
13
Docetaxel Approved May 1996, Investigational Phase 1 114977-28-5 148124 9877265
14 Antimitotic Agents Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer Recruiting NCT03237780 Phase 2 Atezolizumab;Eribulin Mesylate
2 Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery Active, not recruiting NCT02178241 Phase 2 Eribulin Mesylate;Gemcitabine Hydrochloride
3 Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Active, not recruiting NCT00365157 Phase 1, Phase 2 Eribulin Mesylate
4 Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Recruiting NCT02496208 Phase 1 Cabozantinib S-malate
5 Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer Recruiting NCT02437370 Phase 1 Pembrolizumab;Docetaxel;Gemcitabine Hydrochloride

Search NIH Clinical Center for Urethra Transitional Cell Carcinoma

Genetic Tests for Urethra Transitional Cell Carcinoma

Anatomical Context for Urethra Transitional Cell Carcinoma

MalaCards organs/tissues related to Urethra Transitional Cell Carcinoma:

38
Kidney

Publications for Urethra Transitional Cell Carcinoma

Variations for Urethra Transitional Cell Carcinoma

Expression for Urethra Transitional Cell Carcinoma

Search GEO for disease gene expression data for Urethra Transitional Cell Carcinoma.

Pathways for Urethra Transitional Cell Carcinoma

GO Terms for Urethra Transitional Cell Carcinoma

Sources for Urethra Transitional Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....